4//SEC Filing
NOUGUES MAXIMO F 4
Accession 0001437749-22-026032
CIK 0001401667other
Filed
Nov 3, 8:00 PM ET
Accepted
Nov 4, 4:13 PM ET
Size
4.6 KB
Accession
0001437749-22-026032
Insider Transaction Report
Form 4
NOUGUES MAXIMO F
Chief Financial Officer
Transactions
- Sale
Common Stock
2022-11-02$2.25/sh−163$367→ 111,085 total
Footnotes (1)
- [F1]The sales reported in this Form 4 were to satisfy tax obligations in connection with the vesting of restricted stock units in accordance with the Company's mandatory sale to cover taxes program.
Documents
Issuer
PUMA BIOTECHNOLOGY, INC.
CIK 0001401667
Entity typeother
Related Parties
1- filerCIK 0001758507
Filing Metadata
- Form type
- 4
- Filed
- Nov 3, 8:00 PM ET
- Accepted
- Nov 4, 4:13 PM ET
- Size
- 4.6 KB